Development of CRISPR as a Prophylactic Strategy to Combat Novel Coronavirus and Influenza

doi 10.1101/2020.03.13.991307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Distinguishing the Novel Coronavirus From Influenza

Journal of Paramedic Practice
2020English

Targeting Organic Anion Transporter 3 With Probenecid as a Novel Anti-Influenza a Virus Strategy

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Development of Cefotaxime Impregnated Chitosan as Nano-Antibiotics: De Novo Strategy to Combat Biofilm Forming Multi-Drug Resistant Pathogens

Frontiers in Microbiology
Microbiology
2016English

Discovery of Peptidomimetric Antagonists of Estrogen Receptor - Coactivator Interactions: A Novel Strategy to Combat Tamoxifen Drug Resistance

2001English

A Further Strategy to Combat the High Price of Anticancer Drugs

Nature Reviews Clinical Oncology
Oncology
2017English

Defecting 2’-O Methyltransferase as a Novel Strategy for Live Attenuated Vaccine Development

Journal of Human Virology & Retrovirology
2016English

Pop In, Pop Out: A Novel Gene-Targeting Strategy for Use With CRISPR-Cas9

Genome Biology
2015English

A Novel Strategy for Exploring the Reassortment Origins of Newly Emerging Influenza Virus

Bioinformation
2011English

Autodissemination of Pyriproxyfen as Novel Strategy to Control Dengue Outbreaks: A Review

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy